U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685795) titled 'Abuse Liability of Four Modern Oral Nicotine Products' on June 29.
Brief Summary: This is a single-site, open-label, randomized, 6-way crossover study designed to evaluate elements of abuse liability (AL) including subjective effects, physiological measures (pharmacodynamics [PD]), and plasma nicotine uptake (pharmacokinetics [PK]) during controlled monitored use and following ad libitum use of the study investigational products (IPs) by generally healthy smokers who are also users of smokeless tobacco.
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Smoking
Smoking Behaviors
Tobacco Use
Tobacco Smoking
Intervent...